Agios Pharmaceuticals (AGIO) Deferred Taxes (2012)

Agios Pharmaceuticals (AGIO) posted Deferred Taxes of $1.9 million for Q4 2012, up 30.3% on a QoQ basis from $1.5 million in Q3 2012.

Agios Pharmaceuticals (AGIO) Deferred Taxes (2012) Analysis & Trends

Agios Pharmaceuticals' Deferred Taxes history runs 1 years deep, the most recent figure standing at $1.9 million for Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-65.30 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	96.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Agios Pharmaceuticals	2.13 Bn	2.13 Bn	19.43 Mn	-

Download Data

Date	Value
Dec 31, 2012	1.92 Mn
Sep 30, 2012	1.47 Mn